ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

VCYT Veracyte Inc

22.54
0.78 (3.58%)
21 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Veracyte Inc VCYT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.78 3.58% 22.54 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
21.85 21.81 22.55 22.54 21.76
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/6/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202415:27EDGAR2Form 8-K - Current report
12/6/202415:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/6/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202415:05BWVeracyte Announces that New Afirma GRID Data Suggest..
30/5/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202415:26EDGAR2Form 144 - Report of proposed sale of securities
22/5/202415:05BWVeracyte Announces Multiple Afirma GRID Presentations at..
15/5/202416:04BWVeracyte to Participate in Upcoming Investor Conferences
08/5/202416:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202415:10EDGAR2Form 8-K - Current report
07/5/202415:05BWVeracyte Announces First Quarter 2024 Financial Results
06/5/202415:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
22/4/202416:00BWVeracyte to Release First Quarter 2024 Financial Results on..
22/4/202407:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
16/4/202407:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
08/3/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:27EDGAR2Form 8-K - Current report
29/2/202416:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
29/2/202416:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202415:40EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/2/202407:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202416:55BWVeracyte’s Decipher Prostate Test Receives Highest..
22/2/202415:12EDGAR2Form 8-K - Current report
22/2/202415:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
21/2/202416:00BWVeracyte to Participate in the Raymond James 45th Annual..
13/2/202415:15EDGAR2Form 8-K - Current report
08/2/202407:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
06/2/202407:23EDGAR2Form 8-K - Current report
06/2/202407:15BWVeracyte Completes Acquisition of C2i Genomics
29/1/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202407:12EDGAR2Form 8-K - Current report
08/1/202407:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..